Trends in new psychoactive substances from surface and “dark” net monitoring

The Lancet Psychiatry

Volumn 4, Issue 1, 2017, Pages 16-18

  Van Buskirk, Joe ^a   Griffiths, Paul ^b   Farrell, Michael ^a   Degenhardt, Louisa ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b European Monitoring Center for Drugs and Drug Addiction   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DIAMORPHINE; FENTANYL; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT;

CONSUMER; DRUG DEPENDENCE; DRUG LEGISLATION; DRUG MARKETING; DRUG MONITORING; DRUG PURITY; HARM REDUCTION; HUMAN; LAW ENFORCEMENT; NOTE; ONLINE SYSTEM; ORGANIZATION AND MANAGEMENT; PHYSICAL VIOLENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SUBSTANCE USE; COMMERCIAL PHENOMENA; DRUG CONTROL; ECONOMICS; EUROPEAN UNION; INTERNET; LEGISLATION AND JURISPRUDENCE; TRENDS;

COMMERCE; DRUG AND NARCOTIC CONTROL; EUROPEAN UNION; HUMANS; INTERNET; PSYCHOTROPIC DRUGS;

EID: 85008245574     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(16)30405-9     Document Type: Note

References (11)

1. 1 European Monitoring Centre for Drugs and Drug Addiction. Responding to New Psychoactive Substances, 2011, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.
2. 2 Walsh, C, Drugs, the Internet and change. J Psychoactive Drugs 43 (2011), 55–63.
3. 3 Madras, BK, The Growing Problem of New Psychoactive Substances (NPS). Curr Top Behav Neurosci, 2016, 10.1007/7854_2016_34 published online Aug 30.
4. 4 Mounteney, J, Bo, A, Klempova, D, Oteo, A, Vandam, L, The Internet and drug markets: Summary of results from an EMCDDA Trendspotter study, 2014, European Monitoring Centre on Drugs and Drug Addiction, Lisbon http://www.emcdda.europa.eu/publications/technical-reports/internet-drug-markets (accessed Nov 27, 2016).
5. 5 Van Buskirk, J, Naicker, S, Roxburgh, A, Bruno, R, Burns, L, Drugs and the Internet, Issue 6, 2016, National Drug and Alcohol Research Centre, Sydney https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/Drugs%26TheInternet_Newsletter_Issue6.pdf (accessed Nov 27, 2016).
6. 6 Burns, L, Roxburgh, A, Matthews, A, Bruno, R, Lenton, S, Van Buskirk, J, The rise of new psychoactive substance use in Australia. Drug Test Anal 6 (2014), 846–849.
7. 7 Bancroft, A, Scott Reid, P, Concepts of illicit drug quality among darknet market users: purity, embodied experience, craft and chemical knowledge. Int J Drug Policy 35 (2016), 42–49.
8. 8 Barratt, MJ, Ferris, JA, Winstock, AR, Safer scoring? Cryptomarkets, social supply and drug market violence. Int J Drug Policy 35 (2016), 24–31.
9. 9 Drug Enforcement Administration. National Heroin Threat Assessment Summary—Updated, 2016, Drug Enforcement Administration, Virginia.
10. 10 Campbell, RJ, Darknet marketplace issues complete ban against a drug. Cryptocoin News, Sept 2, 2016 https://www.cryptocoinsnews.com/darknet-marketplace-issues-complete-ban-drug/.
11. 11 European Monitoring Centre for Drugs and Drug Addiction. EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl] acetamide (acetylfentanyl), 2016, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.